Dashboard
Manage Tickers

INMDInMode Ltd.

Nasdaq inmodemd.com


$ 15.63 $ -0.47 (-2.92 %)    

Tuesday, 27-Aug-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.56 $ 1.42 (0.3 %)
DIA $ 412.95 $ 0.17 (0.04 %)
SPY $ 561.57 $ 0.77 (0.14 %)
TLT $ 97.97 $ -0.17 (-0.17 %)
GLD $ 233.38 $ 0.63 (0.27 %)
$ 15.62
$ 15.93
$ 15.62 x 100
-- x --
$ 15.51 - $ 15.95
$ 15.41 - $ 40.40
731,349
na
1.31B
$ 1.87
$ 6.63
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
CORRECTTION: InMed Ticker Is 'INM'
08/20/2024 11:38:18

inmode-q2-2024-adj-eps-046-beats-038-estimate-sales-102622m-miss-104762m-estimate
InMode Q2 2024 Adj. EPS $0.46 Beats $0.38 ...
08/01/2024 11:04:58

jefferies-downgrades-inmode-to-hold-lowers-price-target-to-19
Jefferies Downgrades InMode to Hold, Lower...
07/23/2024 10:39:42

Jefferies analyst Matthew Taylor downgrades InMode (NASDAQ:INMD) from Buy to Hold and lowers the price target from $21 to $19.

inmode-announces-morpheus8-fda-510k-clearance-for-soft-tissue-contraction-for-fractional-radiofrequency-microneedling
InMode Announces Morpheus8 FDA 510(k) Clea...
07/17/2024 12:05:25

barclays-maintains-overweight-on-inmode-lowers-price-target-to-29
Barclays Maintains Overweight on InMode, L...
07/15/2024 12:58:00

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $33 to $29.

canaccord-genuity-maintains-hold-on-inmode-lowers-price-target-to-16
Canaccord Genuity Maintains Hold on InMode...
07/12/2024 14:12:54

Canaccord Genuity analyst Caitlin Cronin maintains InMode (NASDAQ:INMD) with a Hold and lowers the price target from $21 to ...

needham-reiterates-hold-on-inmode
Needham Reiterates Hold on InMode
07/11/2024 15:11:40

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.

inmode-sees-q2-revenue-between-862m-863m-pro-forma-revenue-between-1024m-1025m-vs-11658m-est-decreases-fy-2024-guidance-to-430m-440m-vs-4795m-est
InMode Sees Q2 Revenue Between $86.2M-$86....
07/11/2024 13:21:32

Expects Q2 Revenue Between $86.2M-$86.3M, Pro-Forma Revenue (including new platform pre-orders) Between $102.4M-$102.5M, Decrea...

needham-reiterates-hold-on-inmode
Needham Reiterates Hold on InMode
05/03/2024 10:17:23

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.

inmode-sees-fy24-adj-eps-of-201---205-vs-249-est
InMode Sees FY24 Adj EPS OF $2.01 - $2.05 ...
05/02/2024 11:16:24

inmode-cuts-fy24-revenue-guidance-from-495m--505m-to-485m---495m-vs-49325m-est
InMode Cuts FY24 Revenue Guidance From $49...
05/02/2024 11:15:21

inmode-q1-adj-032-misses-044-estimate-sales-8028m-miss-9302m-estimate
InMode Q1 Adj $0.32 Misses $0.44 Estimate,...
05/02/2024 11:02:41

InMode (NASDAQ:INMD) reported quarterly earnings of $0.32 per share which missed the analyst consensus estimate of $0.44 by 27....

inmode-defends-its-feminine-rejuvenation-patent-against-btl-industries-review-request
InMode Defends Its Feminine Rejuvenation P...
04/15/2024 11:08:08

InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, responded to the recent petition to th...

barclays-maintains-overweight-on-inmode-lowers-price-target-to-33
Barclays Maintains Overweight on InMode, L...
04/12/2024 13:59:14

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $34 to $33.

btl-petitions-uspto-to-cancel-all-58-claims-of-us-patent-no-8961511-owned-by-the-company-inmode-ltd
BTL Petitions USPTO To Cancel All 58 Claim...
04/11/2024 13:27:53

BTL Industries, Inc., a leading provider of innovative medical aesthetic solutions, petitioned the U.S. Patent Office to cancel...

why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Tilray Brands Shares Are Trading Lower...
04/09/2024 17:12:29

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

needham-reiterates-hold-on-inmode
Needham Reiterates Hold on InMode
04/09/2024 15:53:24

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.

maxeon-solar-technologies-neogen-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Maxeon Solar Technologies, Neogen And Othe...
04/09/2024 11:42:21

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 0.2% on Tuesday. Shares of Maxeon Solar...

Core News & Articles
CORRECTION: OneMedNet Ticker Is 'ONMD'
04/03/2024 11:15:29

a-look-into-healthcare-sector-value-stocks
A Look Into Healthcare Sector Value Stocks
03/11/2024 14:43:58

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION